Acute myeloid leukemia cells fail to activate native human dendritic cells: A potential mechanism of immune evasion

Leukemia

Volumn 24, Issue 11, 2010, Pages 1965-1967

  Wehner, R ^a   Schumacher, P ^a   Bornhauser M ^b   Ehninger, G ^b   Schakel K ^c   Bachmann, M ^a   Schmitz, M ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12P70; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; LETTER; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 78149454898     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.189     Document Type: Letter

References (8)

1. Barrett AJ, Le Blanc K. Immunotherapy prospects for acute myeloid leukaemia. Clin Exp Immunol 2010; 161: 223-232.
2. Vago L, Perna SK, Zanussi M, Mazzi B, Barlassina C, Stanghellini MTL et al. Loss of mismatched HLA in leukemia after stem cell transplantation. N Engl J Med 2009; 361: 478-488.
3. Baessler T, Krusch M, Schmiedel BJ, Kloss M, Baltz KM, Wacker A et al. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans. Cancer Res 2009; 69: 1037-1045.
4. Baessler T, Charton JE, Schmiedel BJ, Grünebach F, Krusch M, Wacker A et al. CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK cell reactivity against human acute myeloid leukemia in humans. Blood 2010; 115: 3058-3069.
5. Schäkel K, Kannagi R, Kniep B, Goto Y, Mitsuoka C, Zwirner J et al. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 2002; 17: 289-301.
6. Schäkel K, von Kietzell M, Hänsel A, Ebling A, Schulze L, Haase M et al. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are strictly controlled by contact with erythrocytes. Immunity 2006; 24: 767-777.
7. Schmitz M, Zhao S, Deuse Y, Schäkel K, Wehner R, Wöhner H et al. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J Immunol 2005; 174: 4127-4134.
8. + dendritic cells and NK cells. Int J Cancer 2009; 124: 358-366.